LINC02631

Across TCGA pan-cancer cohorts, LINC02631 RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated LINC02631 data layer.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher LINC02631 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC02631 expression acts as an unfavorable survival marker, although some lineages such as HNSC and READ show a favorable association.

LIHC, HNSC, and READ are the cancer types where LINC02631 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	OS	Median	III,IV	0.290	0.749	<.001	57	view →
HNSC	OS	Median	II,III,IV	0.739	0.606	.003	31	view →
READ	OS	Median	IV	0.878	0.502	.007	25	view →
BLCA	OS	Tertile	All	0.543	0.370	.012	19	view →
UCS	DFS	Median	IV	0.909	0.416	.008	18	view →
THCA	OS	Tertile	IV	0.511	0.932	.007	18	view →
KIRC	OS	Tertile	II,III,IV	0.401	0.600	.007	18	view →
PRAD	DFS	Quartile	All	0.716	0.884	.001	12	view →
CHOL	OS	Median	All	0.356	0.809	.009	12	view →
ACC	DFS	Tertile	III,IV	0.097	0.508	.010	11	view →
LUAD	OS	Tertile	All	0.492	0.188	.001	11	view →
SKCM	DFS	Quartile	All	0.292	0.173	.011	8	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 21 lineages.

LINC02631–LIHC (OS)

Open the LIHC breakdown →